Tag Archives: Oxford/AstraZeneca vaccine

What is thrombocytopenia, the rare blood condition possibly linked to the AstraZeneca vaccine?

Shutterstock Anthony Zulli, Victoria University; Maja Husaric, Victoria University; Maximilian de Courten, Victoria University, and Vasso Apostolopoulos, Victoria University The federal government has asked Australia’s medical and vaccine regulators to urgently consider the European Medicines Agency’s finding of a possible link between the Oxford/AstraZeneca COVID vaccine and rare blood clots. This follows reports over recent weeks of blood clots in …

Read More »

Oxford/AstraZeneca vaccine’s rollercoaster ride continues, but latest results again suggest it is safe and effective

Michael Head, University of Southampton The Oxford/AstraZeneca vaccine has been quite the political football over the past few months, particularly in the EU. There have been concerns about its efficacy, its safety and its availability, which appear to have lowered trust. As one of the leading COVID-19 vaccines available, it’s vital that it is supported by the general public. The …

Read More »

COVID vaccine weekly: AstraZeneca is safe and effective, but facing supply issues

Megan Clement, The Conversation The European Medicines Agency has said that the Oxford/AstraZeneca vaccine is safe and effective, and not associated with an increased overall risk of developing blood clots. The regulator conducted a review of the vaccine after a small number of people developed blood clots in Europe after receiving the vaccine. Thirteen countries suspended the use of the …

Read More »

Data suggest no increased risk of blood clots from the AstraZeneca vaccine. Australia shouldn’t pause its rollout

Nigel William Crawford, Murdoch Children’s Research Institute; Hazel Clothier, Murdoch Children’s Research Institute, and Jim Buttery, The University of Melbourne Germany, France, Spain and all of Italy also paused their AstraZeneca rollouts, shortly after this article was published. Ireland and the Netherlands have temporarily paused their rollouts of the AstraZeneca COVID vaccine, due to concerns about blood clots. The move …

Read More »

How well does the AstraZeneca vaccine work? An expert reviews the current evidence

Sarah Pitt, University of Brighton When the Oxford/AstraZeneca vaccine was first authorised by the UK Medicines and Healthcare products Regulatory Agency, it was hailed as a milestone in turning the tide on the coronavirus. But in the time since, this highly efficacious vaccine has suffered a lot of reputational damage. In January, the German press and French president Emmanuel Macron …

Read More »

Vaccine diplomacy: how some countries are using COVID to enhance their soft power

Michael Jennings, SOAS, University of London The COVID-19 pandemic has given rise to various new, repurposed or newly popular terms. The newest entry to the pandemic lexicon might be “vaccine diplomacy”, with some countries using their jabs to strengthen regional ties and enhance their own power and global status. In early February, half a million doses of the Chinese Sinopharm …

Read More »

Act like you’re carrying a dangerous coronavirus mutation – because you might be

Zania Stamataki, University of Birmingham South Africa has temporarily halted its rollout of the Oxford/AstraZeneca vaccine after a preliminary study (not yet released or reviewed by other scientists) found it provided limited protection against the South African coronavirus variant for mild and moderate cases of COVID-19. The variant, which has been found worldwide, has presented challenges for all the available …

Read More »